WallStreetZenWallStreetZen

NASDAQ: BTTX
Better Therapeutics Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for BTTX

Based on 1 analyst offering 12 month price targets for Better Therapeutics Inc.
Min Forecast
$14.00+879.02%
Avg Forecast
$14.00+879.02%
Max Forecast
$14.00+879.02%

Should I buy or sell BTTX stock?

Based on 1 analyst offering ratings for Better Therapeutics Inc.
Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BTTX stock forecasts and price targets.

BTTX stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Chardan Capital
Top 2%
99
Strong BuyMaintains$14.00+879.02%2022-11-15

1 of 1

Forecast return on equity

Is BTTX forecast to generate an efficient return?
Company
78.58%
Industry
14.69%
Market
64.75%
BTTX's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is BTTX forecast to generate an efficient return on assets?
Company
20.19%
Industry
13.16%
BTTX is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

BTTX earnings per share forecast

What is BTTX's earnings per share in the next 3 years based on estimates from 3 analysts?
Avg 1 year Forecast
-$1.97-329.07%
Avg 2 year Forecast
-$5.74-767.44%
Avg 3 year Forecast
-$2.66-409.3%

BTTX revenue forecast

What is BTTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$200.0k
Avg 2 year Forecast
$6.9M
Avg 3 year Forecast
$82.7M

BTTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BTTX$1.43$14.00+879.02%Strong Buy
MNPR$2.64$6.00+127.27%Buy
ELDN$2.47$26.00+954.77%Buy
TCON$1.50$10.00+568.90%Buy
APGN$1.57N/AN/A

Better Therapeutics Stock Forecast FAQ

Is Better Therapeutics Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: BTTX) stock is to Strong Buy BTTX stock.

Out of 1 analyst, 1 (100%) are recommending BTTX as a Strong Buy, 0 (0%) are recommending BTTX as a Buy, 0 (0%) are recommending BTTX as a Hold, 0 (0%) are recommending BTTX as a Sell, and 0 (0%) are recommending BTTX as a Strong Sell.

If you're new to stock investing, here's how to buy Better Therapeutics stock.

What is BTTX's earnings growth forecast for 2022-2024?

(NASDAQ: BTTX) Better Therapeutics's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 7.86%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 16.96%.

Better Therapeutics's earnings in 2022 is -$43,704,000.On average, 3 Wall Street analysts forecast BTTX's earnings for 2022 to be -$46,776,192, with the lowest BTTX earnings forecast at -$48,913,176, and the highest BTTX earnings forecast at -$45,588,979. On average, 1 Wall Street analyst forecast BTTX's earnings for 2023 to be -$136,292,052, with the lowest BTTX earnings forecast at -$136,292,052, and the highest BTTX earnings forecast at -$136,292,052.

In 2024, BTTX is forecast to generate -$63,159,732 in earnings, with the lowest earnings forecast at -$63,159,732 and the highest earnings forecast at -$63,159,732.

What is BTTX's revenue growth forecast for 2022-2024?

(NASDAQ: BTTX) Better Therapeutics's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 24.9%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 6.76%.

Better Therapeutics's revenue in 2022 is $0.On average, 1 Wall Street analysts forecast BTTX's revenue for 2022 to be $4,748,852, with the lowest BTTX revenue forecast at $4,748,852, and the highest BTTX revenue forecast at $4,748,852. On average, 1 Wall Street analysts forecast BTTX's revenue for 2023 to be $162,648,181, with the lowest BTTX revenue forecast at $162,648,181, and the highest BTTX revenue forecast at $162,648,181.

In 2024, BTTX is forecast to generate $1,962,463,089 in revenue, with the lowest revenue forecast at $1,962,463,089 and the highest revenue forecast at $1,962,463,089.

What is BTTX's forecast return on assets (ROA) for 2022-2025?

(NASDAQ: BTTX) forecast ROA is 20.19%, which is higher than the forecast US Biotechnology industry average of 13.16%.

What is BTTX's Price Target?

According to 1 Wall Street analyst that have issued a 1 year BTTX price target, the average BTTX price target is $14.00, with the highest BTTX stock price forecast at $14.00 and the lowest BTTX stock price forecast at $14.00.

The Wall Street analyst predicted that Better Therapeutics's share price could reach $14.00 by Nov 15, 2023. The average Better Therapeutics stock price prediction forecasts a potential upside of 879.02% from the current BTTX share price of $1.43.

What is BTTX's Earnings Per Share (EPS) forecast for 2022-2024?

(NASDAQ: BTTX) Better Therapeutics's current Earnings Per Share (EPS) is $0.86. On average, analysts forecast that BTTX's EPS will be -$1.97 for 2022, with the lowest EPS forecast at -$2.06, and the highest EPS forecast at -$1.92. On average, analysts forecast that BTTX's EPS will be -$5.74 for 2023, with the lowest EPS forecast at -$5.74, and the highest EPS forecast at -$5.74. In 2024, BTTX's EPS is forecast to hit -$2.66 (min: -$2.66, max: -$2.66).

What is BTTX's forecast return on equity (ROE) for 2022-2025?

(NASDAQ: BTTX) forecast ROE is 78.58%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.